AMN Healthcare Services Inc (AMN)

Return on equity (ROE)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	210,679	279,987	319,258	382,152	444,050	478,470	460,048	403,018	327,388	220,479	172,523	128,078	70,665	88,839	86,287	92,831	113,988	122,119	126,522	133,182
Total stockholders’ equity	US$ in thousands	831,256	817,169	766,297	955,774	1,043,630	1,132,630	1,039,340	1,080,930	1,162,030	1,042,480	966,382	894,060	819,677	807,073	777,406	749,080	736,742	705,104	680,440	649,986
ROE		25.34%	34.26%	41.66%	39.98%	42.55%	42.24%	44.26%	37.28%	28.17%	21.15%	17.85%	14.33%	8.62%	11.01%	11.10%	12.39%	15.47%	17.32%	18.59%	20.49%

December 31, 2023 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $210,679K ÷ $831,256K
= 25.34%

AMN Healthcare Services Inc.'s return on equity (ROE) has exhibited some fluctuations over the past eight quarters. The ROE ranged from a low of 25.34% in Q4 2023 to a high of 44.26% in Q2 2022. Overall, the trend shows that the company has generally maintained a strong ROE performance, with most quarters reporting ROE figures above 35%. This indicates that the company has been effectively utilizing its shareholders' equity to generate profits. The decline in ROE from Q2 2022 to Q4 2023 may raise some concerns about the company's recent performance, and further analysis is necessary to understand the underlying reasons for this decrease.